EUROPEAN PANEL BACKS SAFETY OF ROCHE'S TAMIFLU

The European Medicines Agency said on Thursday it was recommending no changes in the safety information for Roche's flu drug Tamiflu, following a review of possible links with psychiatric disorders. The Committee for Medicinal Products for Human Use also recommended extending the use of Tamiflu to include prevention of influenza in children between 1 and 13 years.

Reuters (http://today.reuters.com/investing/financeArticle.aspx?type=governmentFilingsNews&storyID=URI:urn:newsml:reuters.com:20051215:MTFH79283_2005-12-15_10-36-26_L15688884:1)